Ligand Pharmaceuticals | LGND - EPS Earnings Per Share


Ligand Pharmaceuticals reported $3.09 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 1.49 1.27 Mar/04 2026
FY2025Q3 Sep/2025 3.09 1.93 1.84 Nov/06 2025
FY2025Q2 Jun/2025 1.60 1.43 1.40 Aug/07 2025
FY2025Q1 Mar/2025 1.33 1.22 1.20 May/08 2025
FY2024Q4 Dec/2024 1.27 1.18 1.05 Feb/27 2025




Eps Change Date
Amgen USD 5.29 0.35 Dec/2025
Arrowhead Research USD -0.11 1.15 Sep/2025
Baxter International USD 0.69 0.1 Sep/2025
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
Insmed USD -1.75 0.05 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Ligand Pharmaceuticals USD 3.09 1.49 Sep/2025
MacroGenics USD 0.27 0.84 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Pacira USD 0.7 0.04 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Veracyte USD 0.51 0.07 Sep/2025